Long-duration vancomycin reduces C. diff recurrence in patients with IBD

Patients with inflammatory bowel disease who received long-duration vancomycin as treatment for Clostridioides difficile infection had lower recurrence rates compared with patients who received a shorter duration of the drug, according to study results.David T. Rubin, MD, FACG, of the IBD Center at University of Chicago Medicine, and colleagues wrote that while previous studies shown vancomycin to be effective in patients with IBD as treatment for CDI, current C. diff guidelines do not specifically address patients with IBD.“There are no definitive guidelines surrounding the choice ofRead More

Share on facebook
Share on twitter
Share on linkedin